Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
Text Size
876 studies found for:    Open Studies | "Connective Tissue Diseases"

Modify this search | How to Use Search Results

Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Cancel
Rank Status Study
1 Recruiting Undifferentiated Connective Tissue Disease Registry
Condition: Undifferentiated Connective Tissue Disease
Intervention: Other: Observation
2 Recruiting Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST
Condition: Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
Interventions: Drug: Placebo capsules;   Drug: Bardoxolone methyl capsules
3 Recruiting Evaluation and Treatment of Patients With Connective Tissue Disease
Condition: Connective Tissue Disorders
Intervention:
4 Recruiting Characteristics and Disease Progression of Mixed Connective Tissue Disease and Systemic Lupus Erythematosus
Conditions: Mixed Connective Tissue Disease (MCTD);   Systemic Lupus Erythematosus (SLE)
Intervention:
5 Recruiting Safety and Tolerability of Topically Applied Bovine Lung Surfactant on Intact Skin
Condition: Skin and Connective Tissue Diseases
Interventions: Drug: Surfactants;   Drug: Saline Solution
6 Recruiting Prevalence of Pulmonary Arterial Hypertension in Patients With Connective Tissue Diseases in Egyptian Patients
Conditions: Connective Tissue Diseases;   Pulmonary Hypertension
Intervention:
7 Recruiting Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD
Conditions: Interstitial Lung Disease;   Scleroderma;   Idiopathic Inflammatory Myositis;   Mixed Connective Tissue Disease
Interventions: Drug: Rituximab;   Drug: Cyclophosphamide
8 Recruiting A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected Via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) Subjects (PREDICTRA)
Conditions: Rheumatoid Arthritis;   Musculoskeletal and Connective Tissue Diseases
Interventions: Drug: Adalimumab;   Other: Placebo
9 Recruiting Determination of Kidney Function
Conditions: Kidney Disease;   Proteinuria;   Autoimmune / Connective Tissue Diseases
Intervention:
10 Not yet recruiting Role of Mesenchymal Stem Cells in Fat Grafting
Conditions: Romberg's Disease;   Craniofacial Microsomia;   Lipodystrophy;   Mixed Connective Tissue Disease
Interventions: Procedure: Fat graft enriched with ex vivo expanded stem cells;   Procedure: Fat graft not enriched with ex vivo expanded stem cells
11 Recruiting Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus
Condition: Active Systemic Lupus Erythematosus
Interventions: Biological: Anifrolumab;   Drug: Placebo
12 Recruiting An Open-Label Trial of Losartan Potassium in Participants With Eosinophilic Esophagitis (EoE)
Condition: Eosinophilic Esophagitis
Intervention: Drug: Losartan Potassium
13 Recruiting Employment and Arthritis: Making it Work
Conditions: Rheumatoid Arthritis;   Ankylosing Spondylitis;   Lupus Erythematosus, Systemic;   Psoriatic Arthritis;   Other Connective Tissue Diseases;   Spondylarthropathy
Intervention: Behavioral: Employment and Arthritis: Making it Work
14 Recruiting Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension
Conditions: Scleroderma, Diffuse;   Scleroderma, Systemic;   Scleroderma, Limited;   Sclerosis, Progressive Systemic;   Skin Diseases;   Connective Tissue Diseases;   Pathologic Processes;   Autoimmune Diseases
Interventions: Drug: Oral Ifetroban;   Drug: Oral Placebo
15 Recruiting The Effect of Ethanol Extract Physalis Angulata Linn in Scleroderma Patients With Standard Therapy
Condition: Scleroderma
Interventions: Other: Physalis angulata ethanol extract;   Other: Placebo
16 Not yet recruiting Relevance of Monitoring Blood and Salivar Levels of Drugs Used in Rheumatic Autoimmune Diseases
Conditions: Systemic Lupus Erythematosus (SLE);   Juvenile SLE;   Cutaneous Lupus
Interventions: Drug: Thalidomide;   Drug: Hydroxychloroquine reduced;   Drug: Hydroxychloroquine high
17 Recruiting The Scleroderma Biorepository and Pathogenesis Study (STOP Scleroderma)
Condition: Scleroderma
Intervention:
18 Not yet recruiting SCLERoderma et Adipose-DErived Stroma Cells
Condition: Systemic Sclerosis
Interventions: Drug: Stromal Vascular fraction;   Drug: Ringer lactate
19 Recruiting Duke Scleroderma Clinic Patient Registry
Conditions: Scleroderma;   Systemic Sclerosis
Intervention: Other: Registry
20 Recruiting Novel Rehabilitation Strategies to Improve Arm Function in Patients With Scleroderma
Conditions: Scleroderma;   Ssc
Intervention: Other: Occupational therapy treatment
To Top

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
† Study has passed its completion date and status has not been verified in more than two years.